{
  "pmcid": "3276362",
  "sha256": "bd891858cebaa1b8de5104f0951d4e5cad47290a75167d052056738a644c31ef",
  "timestamp_utc": "2025-11-09T23:48:02.904475+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.231038961038962,
    "reading_ease": 44.10227272727275,
    "word_count": 264
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "A single-center, prospective cohort study was conducted from July 2005 to June 2008."
      },
      "Participants": {
        "score": 2,
        "evidence": "Forty-two patients undergoing elective endovascular TAAA repair with custom-designed multi-branched stent-grafts were enrolled."
      },
      "Intervention": {
        "score": 1,
        "evidence": "Forty-two patients undergoing elective endovascular TAAA repair with custom-designed multi-branched stent-grafts were enrolled."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to characterize the inflammatory and coagulopathic response after endovascular thoracoabdominal aortic aneurysm (TAAA) repair and evaluate its effect on post-operative renal function."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "White blood cell count (WBC), platelet count, prothrombin time (PT), and creatinine were measured in all patients."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Forty-two patients undergoing elective endovascular TAAA repair with custom-designed multi-branched stent-grafts were enrolled. Four patients were excluded, leaving 38 for analysis."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Four patients were excluded, leaving 38 for analysis."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The 30-day mortality rate was 5% (2/38). All patients had increased WBC (139 ± 80%, P<0.0001), decreased platelet count (56 ± 15%, P<0.0001), and increased PT (median: 17%, IQR 12 - 22%, P<0.0001) post-procedure."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}